Form 8-K - Current report:
SEC Accession No. 0000950170-22-026669
Filing Date
2022-12-16
Accepted
2022-12-16 16:06:23
Documents
13
Period of Report
2022-12-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bdsx-20221214.htm   iXBRL 8-K 66205
2 EX-99.1 bdsx-ex99_1.htm EX-99.1 14972
  Complete submission text file 0000950170-22-026669.txt   215099

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bdsx-20221214.xsd EX-101.SCH 2462
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bdsx-20221214_lab.xml EX-101.LAB 18518
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bdsx-20221214_pre.xml EX-101.PRE 11494
7 EXTRACTED XBRL INSTANCE DOCUMENT bdsx-20221214_htm.xml XML 4881
Mailing Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301
Business Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

EIN.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39659 | Film No.: 221468000
SIC: 8071 Services-Medical Laboratories